Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal

Nu-Tek Manufacturing Facility

Nu-Tek’s state-of-the-art facility, purpose built to provide over 2000 metric tons of animal-free production annually.
Nu-Tek BioSciences is the market leader in 100% animal-free peptones, yeast extracts and hydrolysates.
  • Renewal marks over a decade of Halal compliance, securing critical supply chains for biopharmaceutical growth markets through 2026 and beyond.

MINNETONKA, Minn., Jan. 13, 2026 (GLOBE NEWSWIRE) — Nu-Tek BioSciences, the industry leader in 100% animal-origin-free (AOF) peptones and yeast extracts, announced today that it has successfully renewed its Halal certification from The Islamic Food and Nutrition Council of America (IFANCA). This certification reinforces Nu-Tek’s decade-long standing as a trusted partner to the global pharmaceutical, biotechnology, and industrial fermentation sectors.

Halal certification is essential for materials distributed throughout the Middle East and Southeast Asia—markets currently facing heightened regulatory standards slated for 2026. By maintaining these rigorous standards, Nu-Tek provides its global partners with an ethically sourced, high-performance supply chain that is technically and culturally compliant with evolving international requirements.

“We strive to be the partner that understands both the complex science of raw materials and the specific nuances of our customers’ regional market expectations,” said Tom Yezzi, CEO of Nu-Tek BioSciences. “Our sustained Halal designation enhances our ability to meet the expanding demand for compliant, animal-free ingredients in the world’s fastest-growing biopharmaceutical hubs.”

As the industry shifts toward a more holistic view of raw material qualification, incorporating religious and ethical considerations alongside technical specifications, Nu-Tek remains at the forefront. This designation, paired with the company’s Kosher/Organic certifications, and proprietary Variability Reduction Program (VRP), underscores Nu-Tek’s commitment to providing the most predictable and accessible raw material solutions in the biopharmaceutical industry.

About Nu-Tek BioSciences

Nu-Tek BioSciences is the market leader in the development and manufacturing of high-quality, 100% animal-origin-free (AOF) peptones and protein hydrolysates. Headquartered in Minnetonka, Minnesota, the company operates a state-of-the-art, purpose-built manufacturing facility dedicated to producing superior raw materials for the biopharmaceutical industry. Nu-Tek’s innovative solutions are essential for cell culture and microbial fermentation, supporting the production of vaccines, therapeutics, and other vital biologics. More product information is available at www.nu-tekbiosciences.com.

Media Contact:

Courtney Jones
Director of Commercial Development
cjones@nu-tekbioscience.com
+1(952) 936.3614
www.nu-tekbiosciences.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4e540576-ddcd-4440-9264-e238409147b5

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3db37752-2106-41c7-ad4a-dc17dc2e46e6

Staff

Recent Posts

Adia Med Kicks Off Recruitment Today for Innovative Autism Stem Cell Study

Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today…

2 minutes ago

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

1 hour ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

2 hours ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

2 hours ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

2 hours ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

2 hours ago